Formula (Clobazam Oral Suspension 1)
Clobazam Suspension
Product Images NDC 69238-1535
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 69238-1535). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure G (Clobazam Oral Suspension 10)
Figure H (Clobazam Oral Suspension 11)
Figure I (Clobazam Oral Suspension 12)
Label (Clobazam Oral Suspension 13)
This is a prescription medication containing the active ingredient clobazam in the strength of 25mg per milliliter. It is available as an oral suspension and should be stored in an upright position at controlled room temperature. The medication should be discarded if not used within 90 days of opening. It is intended for oral use and should be shaken well before each use. The package insert should be consulted for complete prescribing information. This medication is considered RX only and dispensed with medication guide and instructions for use. NDC number is 69238-1535-2.*
1 (Clobazam Oral Suspension 14)
This is a description of Clobazam, an oral suspension medication used for specific treatments. The bottle label provides information on the lot number, expiration date, and storage instructions. The medication is manufactured by Amneal Pharmaceuticals LLC, and the label also includes recommended usage guidelines and warnings. The medication is dispensed with two oral syringes and should be used within 90 days of opening. The label also provides contact information for the manufacturer.*
Figure 1 (Clobazam Oral Suspension 2)
Figure 2 (Clobazam Oral Suspension 3)
This is a graph that compares the effectiveness of Placebo, Clobazam Low, Medium, and High. It measures the proportion of patients and the weekly drop seizure frequency reduction from baseline in percentage. The graph shows that Clobazam High has the greatest effectiveness in reducing the weekly drop seizure frequency.*
Figure A (Clobazam Oral Suspension 4)
Figure B (Clobazam Oral Suspension 5)
The text "shake well" is a simple instruction indicating that the contents of the container should be shaken thoroughly before use.*
Figure C (Clobazam Oral Suspension 6)
Figure D (Clobazam Oral Suspension 7)
Figure E (Clobazam Oral Suspension 8)
Figure F (Clobazam Oral Suspension 9)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
